BER inhibited the Caspase-3-iPLA2-COX-2 pathway in the organism, reduced DOX-induced HCC repopulation, and integrated DOX and BER for effective HCC chemotherapy without relapse [100,101,102]. Here, CASP3 is linked to hepatocellular carcinoma.